Axonal polyneuropathy after acute dimethylamine borane intoxication

Arch Neurol. 2006 Jul;63(7):1009-12. doi: 10.1001/archneur.63.7.1009.

Abstract

Objective: To study a patient with axonal polyneuropathy due to acute dimethylamine borane (DMAB) intoxication.

Patient: Confusion and drowsiness in the acute stage, followed by cognitive impairments and polyneuropathy, are reported in a chemical factory worker after acute exposure to DMAB.

Results: Nerve conduction studies indicated axonal polyneuropathy, particularly in the motor nerves. Sural nerve biopsy studies 3 months later revealed an axonal degeneration with a mild decrease of fiber density in the large myelinated fibers. Quantitative sensory testing also disclosed an impairment of pinprick, temperature, and touch sensations. Cutaneous nerve biopsy studies 9 months later demonstrated a moderate loss of epidermal nerves. During the follow-up period of 1.5 years, the clinical features and serial nerve conduction studies showed a steady improvement.

Conclusions: Since DMAB is a new product and has been widely used recently in the manufacturing of semiconductors and electronics, we conclude that DMAB intoxication may produce motor-predominant axonal polyneuropathy and that the establishment of a threshold limit value is warranted.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Axons / pathology
  • Boranes / poisoning*
  • Chemical Industry
  • Dimethylamines / poisoning*
  • Humans
  • Male
  • Neural Conduction
  • Occupational Diseases / chemically induced
  • Occupational Diseases / pathology
  • Polyneuropathies / chemically induced*
  • Polyneuropathies / pathology
  • Sural Nerve / pathology

Substances

  • Boranes
  • Dimethylamines